Search Results | Clinicalinfo

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2461 – 2480 of 3236

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/node/9220

Laboratory Testing: Drug-Resistance Testing

https://clinicalinfo.hiv.gov/node/9221

Diagnosis of HIV Infection in Infants and Children

https://clinicalinfo.hiv.gov/node/9222

https://clinicalinfo.hiv.gov/node/9224

Laboratory Testing: HLA-B* 5701 Screening

https://clinicalinfo.hiv.gov/node/9225

https://clinicalinfo.hiv.gov/node/9226

Saquinavir (Invirase, SQV)

https://clinicalinfo.hiv.gov/node/9227

Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/node/9228

Bacterial Enteric Infections

https://clinicalinfo.hiv.gov/node/9229

Discontinuation or Interruption of Antiretroviral Therapy

https://clinicalinfo.hiv.gov/node/9231

Cryptosporidiosis

https://clinicalinfo.hiv.gov/node/9232

Cystoisosporiasis (Formerly Isosporiasis)

https://clinicalinfo.hiv.gov/node/9233

Fixed-Dose Combinations

https://clinicalinfo.hiv.gov/node/9234

Etravirine (Intelence, ETR)

https://clinicalinfo.hiv.gov/node/9235

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

https://clinicalinfo.hiv.gov/node/9236

https://clinicalinfo.hiv.gov/node/9237

https://clinicalinfo.hiv.gov/node/9238

Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/node/9240

https://clinicalinfo.hiv.gov/node/9241

Pharmacoenhancers

https://clinicalinfo.hiv.gov/node/9242